Hong Kong: Hong Kong healthcare IPO pipeline continues to fl

Hong Kong: Hong Kong healthcare IPO pipeline continues to flow


LaingBuisson News
The IPO market in Hong Kong shows little sign of a slowdown with Microport Scientific medtech subsidiary MicroPort CardioFlow and assisted reproduction diagnostics company Basecare Medical likely to push the button over the next week. Both were pre-marketing their initial public offerings to raise up to US$300m and US$250m each. MicroPort CardioFlow’s plans were delayed…
You must be a HMI Subscriber to view this content.
Adrian Murdoch has more than 25 years’ experience as an international journalist. He started his career at World Link, the magazine of the World Economic Forum. He covered debt capital markets for Reuters in Singapore throughout the Asian Financial Crisis, and then the European Central Bank in Frankfurt. As a freelancer he has worked for Forbes, The Wall Street Journal, Euromoney, the Scotsman and the BBC. The author of a number of books on the classical world, Adrian has written and presented documentaries for Netflix, the History Channel and PBS. He has been covering healthcare markets in Southeast Asia for the past four years.

Related Keywords

China , Beijing , Hong Kong , Zhejiang , Criss Wang , Microport Cardioflow , Shi Wei , Tu Yi , Jp Morgan , National Medical Products Administration , Global Equity Research Arun George , Microport Scientific , Basecare Medical , Port Cardioflow , Global Equity Research , Tharun George , Aesthetic Medicine , Zhejiang Province , Haohai Healthcare , Mediwelcome Healthcare , சீனா , பெய்ஜிங் , ஹாங் காங் , ஜெஜியாங் , க்ரிஸ் வாங் , ஷி வெய் , து இ , ஜ்ப் மோர்கன் , உலகளாவிய பங்கு ஆராய்ச்சி அருண் ஜார்ஜ் , உலகளாவிய பங்கு ஆராய்ச்சி , அருண் ஜார்ஜ் , அழகுணர்ச்சி சார்ந்த மருந்து , ஜெஜியாங் மாகாணம் ,

© 2025 Vimarsana